Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Misfolded alpha-synuclein (AS) and other neurodegenerative disorder proteins display prion-like transmission of protein aggregation. Factors responsible for the initiation of AS aggregation are unknown. To evaluate the role of amyloid proteins made by the microbiota we exposed aged rats and transgenic C . elegans to E . coli producing the extracellular bacterial amyloid protein curli. Rats exposed to curli-producing bacteria displayed increased neuronal AS deposition in both gut and brain and enhanced microgliosis and astrogliosis compared to rats exposed to either mutant bacteria unable to synthesize curli, or to vehicle alone. Animals exposed to curli producing bacteria also had more expression of TLR2, IL-6 and TNF in the brain than the other two groups. There were no differences among the rat groups in survival, body weight, inflammation in the mouth, retina, kidneys or gut epithelia, and circulating cytokine levels. AS-expressing C . elegans fed on curli-producing bacteria also had enhanced AS aggregation. These results suggest that bacterial amyloid functions as a trigger to initiate AS aggregation through cross-seeding and also primes responses of the innate immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A study of Fischer-344 wild-type rats, which spontaneously develop asymptomatic α-synuclein pathology in the enteric nervous system in old age, showed that they will begin to develop pathological α-synuclein deposits in the brain and parkinsonian motor symptoms when their microbiome is disturbed through introduction of Escherichia coli [86, 87].”
From The gut–brain axis in early Parkinson’s disease: from prodrome to prevention (2025) · cites this paper as [86]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Exposure to curli-producing bacteria increases the deposition and accumulation of a-synuclein in intestinal ganglion cells (myenteric plexus and submucosa) and the brain, respectively, as well as increasing the inflammatory response in the brain.131”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“Our findings of microgliosis, astrogliosis and enhanced expression of IL-6, TLR2 and TNF in the brain following curli exposure suggest the occurrence of an enhanced local sterile inflammatory response to AS in the brain.”
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · cited 1×
“The precise role of protein aggregation and inflammation in neurodegeneration remains unclear 33 .”
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Regression Models for Ordinal Data
McCullagh, P. (1980) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1980.tb01109.x · Cited by 4,453
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Self-citationα-Synuclein strains cause distinct synucleinopathies after local and systemic administration
Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130
Peripheral education of the immune system by colonic commensal microbiota
Lathrop, S. K., Bloom, S. M., Rao, S. M., Nutsch, K., Lio, C.-W., Santacruz, N., Peterson, D. A., Stappenbeck, T. S., & Hsieh, C.-S. (2011) · Nature · doi:10.1038/nature10434 · Cited by 1,034 · cited 2×
“The following antibodies were used: α -synuclein (Syn-1; BD Bioscience, San Diego, CA); TNF α , glial fibrillary acidic protein (GFAP) (GA5), TH, and NeuN (Millipore, County Cork, Ireland); β -actin (Sigma-Aldrich, St Louis, MO); NF-κ B p65 and phospho-NF-κ B p65 (Cell Signaling, Beverly, MA); IL-1 β and IL6 (Abcam, C…”
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901
Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin
Zenaro, E., Pietronigro, E., Bianca, V. D., Piacentino, G., Marongiu, L., Budui, S., Turano, E., Rossi, B., Angiari, S., Dusi, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3913 · Cited by 865 · cited 1×
“It has recently been reported that circulating neutrophils contribute to AS pathology in transgenic mice 15 .”
Cited by
The gut microbiota–brain axis in behaviour and brain disorders
Morais, L. H., Schreiber, H. L., & Mazmanian, S. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00460-0 · Cited by 2,149
Interactions between the microbiota, immune and nervous systems in health and disease
Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017) · Nature Neuroscience · doi:10.1038/nn.4476 · Cited by 1,900
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Soto, C., & Pritzkow, S. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0235-9 · Cited by 1,180
The Gut Microbiota and Alzheimer’s Disease
Jiang, C., Li, G., Huang, P., Liu, Z., & Zhao, B. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161141 · Cited by 852
Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Kowalski, K., & Mulak, A. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18087 · Cited by 826
“coli displayed increased neuronal alpha-synuclein (α-syn) deposition in both the gut and brain, and enhanced microgliosis and astrogliosis compared to rats exposed to bacteria without the ability to produce curli.(27) Moreover, in the brain of animals exposed to curli-producing bacteria an increased expression of TLR2…”
BackgroundMicrobiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804
Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health
Parker, A., Fonseca, S., & Carding, S. R. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1638722 · Cited by 702
Heintz‐Buschart, A., Pandey, U., Wicke, T., Sixel‐Döring, F., Janzen, A., Sittig‐Wiegand, E., Trenkwalder, C., Oertel, W. H., Mollenhauer, B., & Wilmes, P. (2018) · Movement Disorders · doi:10.1002/mds.27105 · Cited by 554
“”(11) In animal models, toxins can reach the CNS from the olfactory bulb(12) and aSyn aggregation triggered by toxins or bacterial amyloid proteins in the enteric nervous system can spread to the CNS.(13,14) Several recent studies have reported PD-related changes in bacterial populations in the gut,(15-21) but differe…”
BackgroundInfluentialRole of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease
Kesika, P., Suganthy, N., Sivamaruthi, B. S., & Chaiyasut, C. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118627 · Cited by 479
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S., & Li-Hua, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01353-3 · Cited by 469
“An example of evidence supporting microbiota involvement in PD is the finding that exposure to curli-producing bacteria increases α-synuclein deposition and accumulation in intestinal ganglion cells and the brain, leading to inflammation.(187) Multiple animal experiments have also demonstrated that αsynuclein patholog…”
BackgroundA gut bacterial amyloid promotes α-synuclein aggregation and motor impairment in mice
Sampson, T. R., Challis, C., Jain, N., Moiseyenko, A., Ladinsky, M. S., Shastri, G. G., Thron, T., Needham, B. D., Horvath, I., Debelius, J. W., et al. (2020) · eLife · doi:10.7554/elife.53111 · Cited by 439
Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis
Borghammer, P., & Van Den Berge, N. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191721 · Cited by 419
The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00681-2 · Cited by 392
The role of microbial amyloid in neurodegeneration
Friedland, R. P., & Chapman, M. R. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006654 · Cited by 391
Self-citationGut microbial molecules in behavioural and neurodegenerative conditions
Needham, B. D., Kaddurah-Daouk, R., & Mazmanian, S. K. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-00381-0 · Cited by 379
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Wallen, Z. D., Demirkan, A., Twa, G., Cohen, G., Dean, M. N., Standaert, D. G., Sampson, T. R., & Payami, H. (2022) · Nature Communications · doi:10.1038/s41467-022-34667-x · Cited by 346
The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Megur, A., Baltriukienė, D., Bukelskienė, V., & Burokas, A. (2020) · Nutrients · doi:10.3390/nu13010037 · Cited by 323
“This suggested that bacterial amyloid functions as a trigger initiating alpha-synuclein aggregation through cross-seeding and prime responses of the innate immune system [122].”
Background16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer’s Post-Mortem Brain
Emery, D. C., Shoemark, D. K., Batstone, T. E., Waterfall, C. M., Coghill, J. A., Cerajewska, T. L., Davies, M., West, N. X., & Allen, S. J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00195 · Cited by 317
“The observation that both alpha synuclein and Aβ42 have antimicrobial activity and that the CsgA (Curli) protein expressed by some bacteria (as part of their extracellular biofilm matrix) promotes alpha synuclein fibrillar deposition in the context of Parkinson’s disease (Chen et al., 2016) may suggest a role for biof…”
BackgroundA Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity
Stolzenberg, E., Berry, D., Yang, D., Lee, E. Y., Kroemer, A., Kaufman, S., Wong, G. C. L., Oppenheim, J. J., Sen, S., Fishbein, T., et al. (2017) · Journal of Innate Immunity · doi:10.1159/000477990 · Cited by 284
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
The vermiform appendix impacts the risk of developing Parkinson’s disease
Killinger, B. A., Madaj, Z., Sikora, J. W., Rey, N., Haas, A. J., Vepa, Y., Lindqvist, D., Chen, H., Thomas, P. M., Brundin, P., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar5280 · Cited by 279
“Activation of the immune system, by noninfectious or infectious factors, can modulate PD pathology through the rate of accumulation and transportation of the -synuclein aggregates (23, 79, 80).”
BackgroundPrying into the Prion Hypothesis for Parkinson's Disease
Brundin, P., & Melki, R. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1788-16.2017 · Cited by 275
“Exposure to Escherichia coli, which generate the extracellular amyloid protein curli, has been suggested to trigger -SYN accumulation in the gut and brain (Chen et al., 2016).”
BackgroundHan, Y., Wang, B., Gao, H., He, C., Hua, R., Liang, C., Zhang, S., Wang, Y., Xin, S., & Xu, J. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s384949 · Cited by 265
“coli showed that the neuronal expression level of α-Syn was enhanced in both the submucosal and myenteric plexus, and is also highly expressed in the brain, which provides evidence supporting this notion.(76) Furthermore, the effects of the gut microbiota and their toxins on α-Syn can also be realized through indirect…”
BackgroundThe olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
Rey, N. L., Wesson, D. W., & Brundin, P. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.013 · Cited by 257
“In addition, exposure to the bacterial amyloid protein curli promotes α-syn aggregation (Chen et al., 2016).”
The Microbiome as a Modifier of Neurodegenerative Disease Risk
Fang, P., Kazmi, S. A., Jameson, K. G., & Hsiao, E. Y. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.06.008 · Cited by 226
“, 2015) and oral administration of curli-producing bacteria, but not curlideficient mutant strains, to wild-type rats results in intestinal accumulation of alphasynuclein (Chen et al., 2016).”
BackgroundDesulfovibrio Bacteria Are Associated With Parkinson’s Disease
Murros, K. E., Huynh, V. A., Takala, T. M., & Saris, P. E. J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.652617 · Cited by 218
“coli and Proteus mirabilis evidently play a role as well (Chen et al., 2016; Choi et al., 2018).”
BackgroundThe Role of Gut Bacterial Metabolites in Brain Development, Aging and Disease
Tran, S. M.-S., & Mohajeri, M. H. (2021) · Nutrients · doi:10.3390/nu13030732 · Cited by 210
“coli stimulated immune activity in rat brains, represented by enhanced neuroinflammatory markers, such as upregulated Toll-like receptor 2 (TLR2), interleukin 6, tissue necrosis factor, microgliosis and astrogliosis [224].”
BackgroundThe links between the gut microbiome, aging, modern lifestyle and Alzheimer's disease
Askarova, S., Umbayev, B., Masoud, A.-R., Kaiyrlykyzy, A., Safarova, Y., Tsoy, A., Olzhayev, F., & Kushugulova, A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00104 · Cited by 208
Chidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204
Self-citationWang, L., Zhao, Z., Zhao, L., Zhao, Y., Yang, G., Wang, C., Gao, L., Niu, C., & Li, S. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07711 · Cited by 203
The role of gut microbiota in pathogenesis of Alzheimer's disease
Bostanciklioğlu, M. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14264 · Cited by 200
“Crossing the deteriorated intestinal membrane and reach the CNS through the bloodstream, microbial amyloids increase the nucleation of Ab aggregates (Chen et al. 2016) and triggers a series of inflammatory responses (Friedland and Chapman 2017) that covers increasing in the levels of TLRs 2 and 1,…”
BackgroundInfluentialDisorders of the enteric nervous system — a holistic view
Niesler, B., Kuerten, S., Demir, I. E., & Schäfer, K.-H. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00385-2 · Cited by 196
Gut–brain axis and the spread of α‐synuclein pathology: Vagal highway or dead end?
Breen, D. P., Halliday, G. M., & Lang, A. E. (2019) · Movement Disorders · doi:10.1002/mds.27556 · Cited by 193
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 187
“Changes in intestinal flora produce abnormal metabolites and structural proteins, which may trigger α-syn accumulation [44, 45].”
BackgroundThe microbiome-gut-brain axis in acute and chronic brain diseases
Benakis, C., Martin-Gallausiaux, C., Trezzi, J.-P., Melton, P., Liesz, A., & Wilmes, P. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.009 · Cited by 183
“In the context of PD, one key study has revealed that gavage of rats with the functional amyloid-Curli-producing Escherichia coli, increases motors symptoms, SNCA aggregation and neuronal loss [62].”
Das, T., Jayasudha, R., Chakravarthy, S., Prashanthi, G. S., Bhargava, A., Tyagi, M., Rani, P. K., Pappuru, R. R., Sharma, S., & Shivaji, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-82538-0 · Cited by 179
Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates
Ilie, I. M., & Caflisch, A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00731 · Cited by 178
Does Parkinson’s disease start in the gut?
Lionnet, A., Leclair-Visonneau, L., Neunlist, M., Murayama, S., Takao, M., Adler, C. H., Derkinderen, P., & Beach, T. G. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1777-8 · Cited by 176
“coli producing curli displayed an increased neuronal expression of alpha-synuclein in both the submucosal and myenteric plexus as well as in the brain [14].”
BackgroundThe Role of Functional Amyloids in Bacterial Virulence
Van Gerven, N., Van der Verren, S. E., Reiter, D. M., & Remaut, H. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.07.010 · Cited by 174
Boertien, J. M., Pereira, P. A. B., Aho, V. T. E., & Scheperjans, F. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191711 · Cited by 170
Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice
Choi, J. G., Kim, N., Ju, I. G., Eo, H., Lim, S.-M., Jang, S.-E., Kim, D.-H., & Oh, M. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-19646-x · Cited by 170
Rosario, D., Bidkhori, G., Lee, S., Bedarf, J., Hildebrand, F., Le Chatelier, E., Uhlen, M., Ehrlich, S. D., Proctor, G., Wüllner, U., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108807 · Cited by 167
Gut microbiota and pro/prebiotics in Alzheimer’s disease
Pluta, R., Ułamek-Kozioł, M., Januszewski, S., & Czuczwar, S. J. (2020) · Aging · doi:10.18632/aging.102930 · Cited by 167
“On top of it, to nucleation of β-amyloid peptide aggregates, bacterial amyloid peptides also increase the aggregation of other misfolded proteins such as alpha-synuclein [49].”
BackgroundAutoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells
Garretti, F., Agalliu, D., Lindestam Arlehamn, C. S., Sette, A., & Sulzer, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00303 · Cited by 162
“demonstrated that aged Fisher rats fed amyloid-protein curli-producing Escherichia coli display increased neuronal expression of α-syn in the submucosal and myenteric plexus of the gut as well as in the brain (19).”
BackgroundPeterson, C. T. (2020) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x20957225 · Cited by 160
“coli strain that produced curli had increased production of alphasynuclein in the gut and brain, increased aggregation of alphasynuclein in the brain, and increased neuroinflammation compared to rats exposed to a non-curli producing control.(77) Both PD patient-derived and E.”
BackgroundThe Role of Gut Microbiota in an Ischemic Stroke
Pluta, R. M., Januszewski, S., & Czuczwar, S. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020915 · Cited by 172
“Microbial amyloids trigger the nucleation of amyloid aggregates with a huge accumulation and cause an inflammatory response [60,61].”
BackgroundNeuroinflammation, gut microbiome, and Alzheimer's disease
Lin, L., Zheng, L. J., & Zhang, L. J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0983-2 · Cited by 147
Ivanova, M. I., Lin, Y., Lee, Y., Zheng, J., & Ramamoorthy, A. (2020) · Biophysical Chemistry · doi:10.1016/j.bpc.2020.106507 · Cited by 159
Clinical and imaging evidence of brain-first and body-first Parkinson's disease
Horsager, J., Knudsen, K., & Sommerauer, M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105626 · Cited by 174
Doroszkiewicz, J., Groblewska, M., & Mroczko, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810028 · Cited by 175
“Moreover, the rat brains showed an increased expression of TLR-2, TNF-α, and IL-6, which may indicate that amyloids produced by bacteria provoke α-synuclein aggregation and, as a result, an innate immune system response [109,110].”
BackgroundFu, P., Gao, M., & Yung, K. K. L. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00607 · Cited by 159
The Gut and Parkinson's Disease—A Bidirectional Pathway
Santos, S. F., de Oliveira, H. L., Yamada, E. S., Neves, B. C., & Pereira, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00574 · Cited by 160
“Recent in vivo models showed that accumulation of α-syn aggregates in the ENS can be induced by alterations in the gut microbiome (111).”
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?
Espay, A. J., Kalia, L. V., Gan‐Or, Z., Williams‐Gray, C. H., Bedard, P. L., Rowe, S. M., Morgante, F., Fasano, A. A., Stecher, B., Kauffman, M., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009107 · Cited by 145
“interleukin [IL]-6, and tumor necrosis factor) has been documented in mice or rats in response to infections or inflammation.(25,26) Within this framework, α-syn aggregation may behave not unlike an acute-phase reactant, increasing in concentration during an inflammatory state.”
BackgroundLinking Oxidative Stress and Proteinopathy in Alzheimer’s Disease
Sharma, C., & Kim, S. R. (2021) · Antioxidants · doi:10.3390/antiox10081231 · Cited by 159
Gut microbiome in Parkinson's disease: New insights from meta-analysis
Toh, T. S., Chong, C. W., Lim, S., Bowman, J. S., Cirstea, M. S., Lin, C., Chen, C., Appel‐Cresswell, S., Finlay, B. B., & Tan, A. H. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.11.017 · Cited by 147
The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease
Baizabal-Carvallo, J. F., & Alonso-Juarez, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.030 · Cited by 130
Metta, V., Leta, V., Mrudula, K. R., Prashanth, L. K., Goyal, V., Borgohain, R., Chung-Faye, G., & Chaudhuri, K. R. (2022) · Journal of Neurology · doi:10.1007/s00415-021-10567-w · Cited by 130
“Also, intestinal infection with gram-negative bacteria, in genetically predisposed mice, may trigger PD-like symptoms [16].”
BackgroundThe heterogeneity of Parkinson’s disease
Wüllner, U., Borghammer, P., Choe, C., Csóti, I., Falkenburger, B. H., Gasser, T., Lingor, P., & Riederer, P. F. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02635-4 · Cited by 158
Infection and Risk of Parkinson’s Disease
Smeyne, R. J., Noyce, A. J., Byrne, M., Savica, R., & Marras, C. (2021) · Journal of Parkinson's Disease · doi:10.3233/jpd-202279 · Cited by 125
Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases
Miller, A. L., Bessho, S., Grando, K. C. M., & Tükel, Ç. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.638867 · Cited by 141
“Data from in vitro studies also suggest that crossseeding of Aβ aggregation by bacterial amyloids could initiate AD (Table 1) (127, 144).”
BackgroundBicknell, B. T., Liebert, A. D., Borody, T. J., Herkes, G., McLachlan, C. S., & Kiat, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119577 · Cited by 146
“Rats that are fed bacteria that produce the bacterial amyloid curli deposit α -synuclein in neurons in their gut and brain [252].”
How gut microbes could drive brain disorders
Willyard, C. (2021) · Nature · doi:10.1038/d41586-021-00260-3 · Cited by 124
A peripheral signature of Alzheimer’s disease featuring microbiota-gut-brain axis markers
Marizzoni, M., Mirabelli, P., Mombelli, E., Coppola, L., Festari, C., Lopizzo, N., Luongo, D., Mazzelli, M., Naviglio, D., Blouin, J.-L., et al. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01218-5 · Cited by 121
Caenorhabditis elegans: a model to understand host–microbe interactions
Kumar, A., Baruah, A., Tomioka, M., Iino, Y., Kalita, M. C., & Khan, M. R. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03319-7 · Cited by 138
The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease
Dogra, N., Mani, R. J., & Katare, D. P. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01066-7 · Cited by 133
“Recently many in vivo models have shown that the modulations in the GM may result in the accumulation of aggregates of α-syn in the ENS (Chen et al.”
BackgroundInfluentialSun, M., Ma, K., Wen, J., Wang, G., Zhang, C., Li, Q., Bao, X., & Wang, H. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190872 · Cited by 113
“…been shown to enhance accumulation of (cid:4) -synuclein within the gut and brain of C. elegans fed a diet rich in Curli-producing bacteria, suggesting that this bacterial amyloid protein may facilitate (cid:4) -synuclein aggregation via cross-seeding and priming of the immune response [65].”
Maguire, M., & Maguire, G. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0024 · Cited by 120
Microbiota-brain interactions: Moving toward mechanisms in model organisms
Nagpal, J. K., & Cryan, J. F. (2021) · Neuron · doi:10.1016/j.neuron.2021.09.036 · Cited by 116
Gut microbiota-derived metabolites and their importance in neurological disorders
Swer, N. M., Venkidesh, B. S., Murali, T. S., & Mumbrekar, K. D. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08038-0 · Cited by 131
“Preclinical research suggests that gut microbiota can enhance the aggregation of alpha-synuclein, hamper the elimination process [18], and via the vagus nerve, these proteins can reach from the gut to the brain [19, 20].”
BackgroundSaiyasit, N., Chunchai, T., Prus, D., Suparan, K., Pittayapong, P., Apaijai, N., Pratchayasakul, W., Sripetchwandee, J., Chattipakorn, N., & Chattipakorn, S. C. (2019) · Nutrition · doi:10.1016/j.nut.2019.110576 · Cited by 116
Perov, S., Lidor, O., Salinas, N., Golan, N., Tayeb-Fligelman, E., Deshmukh, M. G., Willbold, D., & Landau, M. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007978 · Cited by 115
Wang, C., Lau, C. Y., Ma, F., & Zheng, C. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2106504118 · Cited by 124
Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease
Chiang, H., & Lin, C. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.18067 · Cited by 113
Gut Microbiota Interaction with the Central Nervous System throughout Life
Ojeda, J., Ávila, A., & Vidal, P. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061299 · Cited by 114
TLR2 and TLR4 in Parkinson’s disease pathogenesis: The environment takes a toll on the gut
Gorecki, A. M., Anyaegbu, C. C., & Anderton, R. S. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00271-0 · Cited by 103
“coli demonstrated increased α-synuclein deposition in submucosal and myenteric ganglia, coupled with central microgliosis, astrogliosis, increased TLR2 expression and α-synuclein aggregation throughout the brain, despite no evidence of bacterial amyloid infiltration into the brain or other tissues [92].”
BackgroundSynucleinopathies: Where we are and where we need to go
Brás, I. C., Dominguez‐Meijide, A., Gerhardt, E., Koss, D. J., Lázaro, D. F., Santos, P. I., Vasili, E., Xylaki, M., & Outeiro, T. F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14965 · Cited by 114
Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties
Pellegrino, A., Coppola, G., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023) · Nutrients · doi:10.3390/nu15081815 · Cited by 112
Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
Alam, M. M., Yang, D., Li, X., Liu, J., Back, T. C., Trivett, A. L., Karim, B. O., Barbut, D., ZASLOFF, M. A., & Oppenheim, J. J. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110090 · Cited by 104
The Gut-Brain Axis in Alzheimer’s Disease and Omega-3. A Critical Overview of Clinical Trials
Rosa, F. L., Clerici, M., Ratto, D., Occhinegro, A., Licito, A., Romeo, M., Iorio, C. D., & Rossi, P. (2018) · Nutrients · doi:10.3390/nu10091267 · Cited by 105
The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists
Lerner, A., Neidhöfer, S., & Matthias, T. (2017) · Microorganisms · doi:10.3390/microorganisms5040066 · Cited by 106
“Recently, a new pathway was reported where a bacterial amyloid functions as a trigger to induce α-synuclein accumulation through cross-seeding and priming the innate immune system, in animal models [175].”
BackgroundOral Dysbiosis and Inflammation in Parkinson’s Disease
Fleury, V., Zekeridou, A., Lazarević, V., Gaïa, N., Giannopoulou, C., Genton, L., Cancela, J., Girard, M., Goldstein, R., Bally, J. F., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202459 · Cited by 107
“coli mutant lacking the ability to produce bacterial amyloid protein [75].”
BackgroundGut Inflammation in Association With Pathogenesis of Parkinson’s Disease
Chen, Q.-Q., Haikal, C., Li, W., & Li, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00218 · Cited by 97
“Photobiomics”: Can Light, Including Photobiomodulation, Alter the Microbiome?
Liebert, A. D., Bicknell, B. T., Johnstone, D. M., Gordon, L. C., Kiat, H., & Hamblin, M. R. (2019) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1089/photob.2019.4628 · Cited by 96
“elegans models of Parkinson’s disease show increased aggregation of a-synuclein as well as increased neural inflammation when exposed to bacteria that produce ‘‘curli’’, a bacterial amyloid protein.(141) The intestinal microbiome appears to have a causal role in the development and progression of atherosclerosis.”
BackgroundVaresi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
“, gut bacteria may induce the aggregation of α-synuclein in ENS), which, propagating in a prion-like manner, passes to the brain through the vagus nerve [15,19,20].”
BackgroundThe Gut and Parkinson’s Disease: Hype or Hope?
Scheperjans, F., Derkinderen, P., & Borghammer, P. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181477 · Cited by 101
The gut microbiome and Alzheimer’s disease: Complex and bidirectional interactions
Tarawneh, R. M., & Penhos, E. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104814 · Cited by 96
Gastrointestinal Dysfunction in Parkinson’s Disease
Skjærbæk, C., Knudsen, K., Horsager, J., & Borghammer, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030493 · Cited by 94
“Interestingly, exposure to Escherichia coli producing the protein curli enhances the aggregation of α-syn in aged Fischer rats [34].”
BackgroundMicrobiome changes: an indicator of Parkinson’s disease?
Haikal, C., Chen, Q., & Li, J. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0175-7 · Cited by 88
Bacterial DNA promotes Tau aggregation
Tetz, G. V., Pinho, M. A., Pritzkow, S., Méndez, N., Soto, C. A., & Tetz, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-59364-x · Cited by 82
Microbiome, Parkinson’s Disease and Molecular Mimicry
Miraglia, F., & Colla, E. (2019) · Cells · doi:10.3390/cells8030222 · Cited by 90
“elegans line overexpressing αS, induced increased neuronal αS deposition in both the gut and the brain tissues [131].”
BackgroundStructural analysis and architectural principles of the bacterial amyloid curli
Sleutel, M., Pradhan, B., Volkov, A. N., & Remaut, H. K. (2023) · Nature Communications · doi:10.1038/s41467-023-38204-2 · Cited by 85
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
Teil, M., Arotçarena, M.-L., Faggiani, E., Laferrière, F., Bézard, E., & Dehay, B. (2020) · Biomolecules · doi:10.3390/biom10030391 · Cited by 84
Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
Kasen, A., Houck, C., Burmeister, A. R., Sha, Q., Brundin, L., & Brundin, P. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105654 · Cited by 78
“also reported amyloid curli producing Escherichia coli induced α-syn aggregation in aged rats and Caenorhabditis elegans (Chen et al., 2016).”
Tetz, G. V., Brown, S. M., Hao, Y., & Tetz, V. (2019) · Scientific Reports · doi:10.1038/s41598-019-46087-x · Cited by 82
“…a trans-kingdom interplay between E. coli curli fibers and alpha-synuclein aggregation in the gut and brain of Parkinson’s disease models, and in triggering amyloidosis in systemic lupus erythematosus following Salmonella typhimurium curli-DNA treatment (Gallo et al., 2015; Chen et al., 2016).”
BackgroundInfluentialCan infections trigger alpha-synucleinopathies?
Tulisiak, C. T., Mercado, G., Peelaerts, W., Brundin, L., & Brundin, P. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.002 · Cited by 80
Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease
Huang, Y., Liao, J., Liu, X., Zhong, Y., Cai, X., & Long, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.615075 · Cited by 83
“The repeated administration of Curli-producing bacteria in rats can enhance microgliosis, astrogliosis, and cytokine production (Chen et al., 2016).”
BackgroundDe novo designed protein inhibitors of amyloid aggregation and seeding
Murray, K. A., Hu, C. J., Griner, S. L., Pan, H., Bowler, J. T., Abskharon, R. N. N., Rosenberg, G. M., Cheng, X., Seidler, P. M., & Eisenberg, D. S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206240119 · Cited by 85
Chen, S., & Lin, C. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00839-6 · Cited by 92
“Induction of abnormal alpha-synuclein aggregation by curli has been demonstrated in vitro, and ingestion of curli and curli-producing bacteria accelerates enteric and central alpha-synucleinopathy, as well as neuroinflammation, dopaminergic neuronal degeneration, and motor dysfunction, in transgenic rodent models of P…”
BackgroundSelf-citationLorente-Picón, M., & Laguna, A. (2021) · Biomolecules · doi:10.3390/biom11030433 · Cited by 69
“Emerging evidence has shown that protein nucleation and aggregation may be influenced by an extracellular amyloid protein called “curli” secreted by Escherichia Coli [80] inducing neuronal deposition of a-syn in the gut and promoting neuroinflammation.”
BackgroundChen, T.-J., Feng, Y., Liu, T., Wu, T.-T., Chen, Y.-J., Li, X., Li, Q., & Wu, Y.-C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.549037 · Cited by 69
Metadata
- Authors
- Chen, S. G., Stribinskis, V., Rane, M. J., Demuth, D. R., Gozal, E., Roberts, A. M., Jagadapillai, R., Liu, R., Choe, K., Shivakumar, B., Son, F., Jin, S., Kerber, R., Adame, A., Masliah, E., & Friedland, R. P.
- Affiliations
- Case Western Reserve University (US)
- University of Louisville (US)
- University of California San Diego (US)
- Corresponding author
- Friedland, Robert P.
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-10-06
- Volume
- 6
- Issue
- 1
- Pages
- 34477-34477
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5052651
- OpenAlex
- W2528438579
- Semantic Scholar
- 8941d2a0855c5ed0f4d041db3a0b4426e019b757
- Cited by
- 463
- References
- 53
- Citations by year
- 2026: 27 · 2025: 44 · 2024: 62 · 2023: 57 · 2022: 72 · 2021: 74 · 2020: 45 · 2019: 45 · 2018: 17 · 2017: 19 · 2016: 1
- FWCI
- 20.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- University of Louisville
- National Institute on Aging (P50AG005131)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- alpha-synuclein aggregation, curli, bacterial amyloids, prion-like transmission, cross-seeding, gut microbiota, neuroinflammation, microglial activation, astrocyte activation, innate immune response, TLR2, interleukin-6, TNF-α, aged rats, Caenorhabditis elegans, Escherichia coli, neurodegenerative diseases
- MeSH terms
- Amyloid, Animals, Bacterial Proteins, Escherichia coli, Rats, Inbred F344, Caenorhabditis elegans, Escherichia coli Proteins, Rats, alpha-Synuclein, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.